154 related articles for article (PubMed ID: 38067227)
1. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
[TBL] [Abstract][Full Text] [Related]
2. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
Kahm YJ; Kim RK
Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
[TBL] [Abstract][Full Text] [Related]
3. KIF4A promotes epithelial-mesenchymal transition by activating the TGF-β/SMAD signaling pathway in glioma cells.
Xu Y; Xue G; Zhou L; Wu G; Hu L; Ma S; Zhang J; Li X
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38411896
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.
Matsumoto Y; Saito M; Saito K; Kanke Y; Watanabe Y; Onozawa H; Hayase S; Sakamoto W; Ishigame T; Momma T; Kumamoto K; Ohki S; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2188-2194. PubMed ID: 29434924
[TBL] [Abstract][Full Text] [Related]
5. RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Kim RK
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047826
[TBL] [Abstract][Full Text] [Related]
6. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells.
Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C
Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
Cho SY; Kim S; Kim G; Singh P; Kim DW
Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
10. KIF4A drives gliomas growth by transcriptional repression of Rac1/Cdc42 to induce cytoskeletal remodeling in glioma cells.
Zhang H; Meng S; Chu K; Chu S; Fan YC; Bai J; Yu ZQ
J Cancer; 2022; 13(15):3640-3651. PubMed ID: 36606197
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
12. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
13. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
14. DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.
Yang M; Zhang H; Gao S; Huang W
J Orthop Surg Res; 2023 Feb; 18(1):145. PubMed ID: 36849972
[TBL] [Abstract][Full Text] [Related]
15. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
[TBL] [Abstract][Full Text] [Related]
16. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
[TBL] [Abstract][Full Text] [Related]
17. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
Zhang J; An L; Zhao R; Shi R; Zhou X; Wei S; Zhang Q; Zhang T; Feng D; Yu Z; Wang H
Mol Carcinog; 2023 Mar; 62(3):303-318. PubMed ID: 36468837
[TBL] [Abstract][Full Text] [Related]
18. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
19. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
[TBL] [Abstract][Full Text] [Related]
20. Cdk1-dependent phosphorylation of KIF4A at S1186 triggers lateral chromosome compaction during early mitosis.
Takata H; Madung M; Katoh K; Fukui K
PLoS One; 2018; 13(12):e0209614. PubMed ID: 30576375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]